Cumulative advantages and social capabilities in scientific mobility in the Health Sciences: The Spanish case
RESEARCH ARTICLE
Cumulative advantages and social capabilities
in scientific mobility in the Health Sciences:
The Spanish case
Pedro Aceituno-Aceituno1*, Lorenzo Melchor2, Joaquı́n Danvila-del-Valle3,
Carlos Bousoño-Calzón4
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
1 Departamento de Administración y Dirección de Empresas y Economı́a, Universidad a Distancia de Madrid
(UDIMA), Collado Villalba (Madrid), España, 2 Independent Researcher, London, United Kingdom,
3 Departamento de Administración y Dirección de Empresas y Economı́a, Universidad a Distancia de Madrid
(UDIMA), Collado Villalba (Madrid), España, 4 Departamento de Teorı́a de la Señal y Comunicaciones,
Universidad Carlos III de Madrid (UCIIIM), Leganés (Madrid), España
*
Abstract
OPEN ACCESS
Citation: Aceituno-Aceituno P, Melchor L, Danviladel-Valle J, Bousoño-Calzón C (2017) Cumulative
advantages and social capabilities in scientific
mobility in the Health Sciences: The Spanish case.
PLoS ONE 12(3): e0173204. doi:10.1371/journal.
pone.0173204
Background
The big problem in global public health, arising from the international migration of physicians
from less-developed to more-developed countries, increases if this migration also affects scientists dedicated to health areas. This article analyzes critical variables in the processes of
Spanish scientific mobility in Health Sciences to articulate effective management policies for
the benefit of national public health services and the balance between local and global science.
Editor: J. Alberto Conejero, IUMPA - Universitat
Politecnica de Valencia, SPAIN
Received: June 29, 2016
Accepted: February 16, 2017
Published: March 15, 2017
Copyright: © 2017 Aceituno-Aceituno et al. This is
an open access article distributed under the terms
of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by the
Ministerio de Empleo y Seguridad Social de
España/Dirección General de Migraciones (http://
www.empleo.gob.es/es/) Expediente N˚. 3.34/13.
Novanca/Caja Rural (http://www.novanca.com)
Contrato de Investigación de la Universidad Carlos
III de Madrid con Novanca/Caja Rural. The funders
had no role in study design, data collection and
Methods
This study develops a survey to measure and analyze the following crucial variables:
research career, training, funding, working with a world-class team, institutional prestige,
wages, facilities/infrastructure, working conditions in the organization of the destination
country, fringe benefits in the organization of the destination country and social responsibility
in the organization of the departure country. A total of 811 researchers have participated in
the survey, of which 293 were from the health sector: Spanish scientists abroad (114), scientists that have returned to Spain (32) and young researchers in Spain (147).
Results
The most crucial variables for Spanish scientists and young researchers in Spain in Health
Sciences moving abroad are the cumulative advantages (research career, training, funding
and institutional prestige) plus wages. On the other hand, the return of Spanish scientists in
the Health Sciences is influenced by cumulative variables (working with a world-class team,
research career and institutional prestige) and also by other variables related to social factors, such as working conditions and fringe benefits in the destination country. Permanent
positions are rare for these groups and their decisions regarding mobility depend to a large
extent on job opportunities.
PLOS ONE | DOI:10.1371/journal.pone.0173204 March 15, 2017
1 / 23
Cumulative advantages and social capabilities in scientific mobility
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist. This study was
supported by Novanca/Caja Rural (http://www.
novanca.com) Contrato de Investigación de la
Universidad Carlos III de Madrid con Novanca/Caja
Rural. This does not alter adherence to PLOS ONE
policies on data sharing. There are no relevant
declarations relating to employment, consultancy,
patents, products in development, marketed
products, to declare.
Abbreviations: ACE Japón, Asociación de
Cientı́ficos Españoles en Japón; ACES, Association
of Spanish Scientists in Sweden/Asociación de
Cientı́ficos Españoles en Suecia; AES, Acción
Estratégica de Salud; CED, Spanske Forskere i
Danmark/Cientı́ficos Españoles en Dinamarca;
CERFA, Cientı́ficos Españoles en la República
Federal de Alemania; COFIS, Colegio Oficial de
Fı́sicos; ECUSA, Comunidad de Españoles
Cientı́ficos en Estados Unidos; FEBiotec,
Federación Española de Biotecnólogos; FECYT,
Spanish Foundation for Science and Technology
/Fundación Española para la Ciencia y la
Tecnologı́a; FUE, Fundación Universidad-Empresa;
MEC, Ministerio de Educación y Ciencia; R&D&i,
Research, Development and Innovation; RedIEX,
Sistema de Comunicación con Investigadores en el
Exterior; SECTI, Sistema Español de Ciencia y
Tecnologı́a; SNS, Sistema Nacional de Salud;
SRAP/IEAP, Spanish Researchers in AustraliaPacific/Investigadores Españoles en AustraliaPacı́fico; SRS / CRE, Scientists returned to Spain /
Cientı́ficos retornados a España; SRUK/CERU,
Society of Spanish Researchers in the United
Kingdom/Comunidad de Cientı́ficos Españoles en el
Reino Unido; SSA / CIEX, Spanish scientists
abroad / Cientı́ficos españoles en el exterior; YRS /
JIES, Young researchers in Spain / Jóvenes
investigadores en España.
Conclusions
Spanish health organizations can influence researchers to return, since these decisions
mainly depend on job opportunities. These organizations can complement the cumulative
advantages offered by the wealthier countries with the intensification of social factors.
Introduction
Accelerated international migration, from less developed to more developed countries, has
reduced the number of physicians in poor countries [1]. This one-sided migration is a big
global public health problem that also affects middle-income countries [2]. The incorporation
of scientists to health services not only encourages medical research in health services [3,4],
but also improves researchers´ performance in translational research [5]. However, when the
brain drain involves health scientists, these beneficial effects, as well as the rapid incorporation
of research advances into clinical practice, do not occur. Curing patients becomes a long and
expensive process and results in a worse diagnosis and treatment [6].
The business sector also benefits from inventing, testing and commercializing new drugs,
vaccines, and medical equipment that are normally protected by patents and may provide better diagnoses and treatments for patients. Gove (...truncated)